Literature DB >> 34939750

Integrative computational approach identifies immune-relevant biomarkers in ulcerative colitis.

Tianzhen He1, Kai Wang2, Peng Zhao3,4, Guanqun Zhu5, Xinbao Yin5, Yulian Zhang6, Zongliang Zhang5, Kai Zhao5, Zhenlin Wang5, Ke Wang5.   

Abstract

Ulcerative colitis is a common inflammatory bowel disease with a complex genetic and immune etiology. Immune infiltration plays a vital role in the development of ulcerative colitis. To explore potential biomarkers for ulcerative colitis and analyze characteristics of immune cell infiltration, we used bioinformatic analyses, including machine learning algorithms, cell type deconvolution methods, and pathway enrichment methods. In this study, we identified 216 differentially expressed mRNAs (DEMs), of which 153 were upregulated, and 63 were downregulated genes. DEMs were mainly enriched in infiltrating neutrophils and regulation of leukocyte migration. Moreover, eight candidate biomarkers, DPP10, MST1L, DPP10-AS1, CEP55, ACSL1, MGP, OLFM4, and SGK1, were identified. Of these candidate biomarkers, MST1L, OLFM4, and DPP10 were then validated in the GSE48958 dataset and were predicted to be strongly correlated with infiltrating immune cells of ulcerative colitis. The underlying mechanism of these key genes in the development of colitis was also predicted by gene set variation analysis. To further validate these biomarkers' expression in ulcerative colitis, we determined mRNA levels of SGK1, CEP55, ACSL1, OLFM4, and DPP10 in lipopolysaccharides (LPS)-stimulated Raw264.7 cells by quantitative reverse transcription-polymerase chain reaction. We also examined SGK1, CEP55, ACSL1, OLFM4, DPP10, and MGP expression in the colon tissues of dextran sodium sulfate-induced colitis mice. Consistent with the predicted computational results, the mRNA levels of these candidate genes were markedly changed in LPS-stimulated Raw264.7 cells and inflamed colon tissues. Hence, our findings indicated that these critical genes may act as diagnostic biomarkers for ulcerative colitis and that differential immune infiltration cells may help illustrate the progression of ulcerative colitis.
© 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.

Entities:  

Keywords:  bioassay; computational approach; immune-related biomarkers; leukocyte migration; ulcerative colitis

Mesh:

Substances:

Year:  2022        PMID: 34939750      PMCID: PMC8804607          DOI: 10.1002/2211-5463.13357

Source DB:  PubMed          Journal:  FEBS Open Bio        ISSN: 2211-5463            Impact factor:   2.693


  31 in total

1.  OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.

Authors:  Laurens G van der Flier; Andrea Haegebarth; Daniel E Stange; Marc van de Wetering; Hans Clevers
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

2.  T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.

Authors:  Jie Yan; Surya P Pandey; Betsy J Barnes; Jerrold R Turner; Clara Abraham
Journal:  Cell Rep       Date:  2020-06-30       Impact factor: 9.423

3.  DPP10 modulates Kv4-mediated A-type potassium channels.

Authors:  Edward Zagha; Andres Ozaita; Su Ying Chang; Marcela S Nadal; Udele Lin; Michael J Saganich; Tom McCormack; Karen O Akinsanya; Shu Y Qi; Bernardo Rudy
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

Review 4.  The role of neutrophils during intestinal inflammation.

Authors:  B M Fournier; C A Parkos
Journal:  Mucosal Immunol       Date:  2012-04-11       Impact factor: 7.313

5.  Immune Protection of a Helminth Protein in the DSS-Induced Colitis Model in Mice.

Authors:  Shao Rong Long; Ruo Dan Liu; Deepak Vijaya Kumar; Zhong Quan Wang; Chien-Wen Su
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

6.  NCBI GEO: archive for functional genomics data sets--update.

Authors:  Tanya Barrett; Stephen E Wilhite; Pierre Ledoux; Carlos Evangelista; Irene F Kim; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Michelle Holko; Andrey Yefanov; Hyeseung Lee; Naigong Zhang; Cynthia L Robertson; Nadezhda Serova; Sean Davis; Alexandra Soboleva
Journal:  Nucleic Acids Res       Date:  2012-11-27       Impact factor: 16.971

7.  Robust enumeration of cell subsets from tissue expression profiles.

Authors:  Aaron M Newman; Chih Long Liu; Michael R Green; Andrew J Gentles; Weiguo Feng; Yue Xu; Chuong D Hoang; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Methods       Date:  2015-03-30       Impact factor: 28.547

Review 8.  New developments in ulcerative colitis: latest evidence on management, treatment, and maintenance.

Authors:  Kartikeya Tripathi; Joseph D Feuerstein
Journal:  Drugs Context       Date:  2019-04-29

9.  GSVA: gene set variation analysis for microarray and RNA-seq data.

Authors:  Sonja Hänzelmann; Robert Castelo; Justin Guinney
Journal:  BMC Bioinformatics       Date:  2013-01-16       Impact factor: 3.169

10.  Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.

Authors:  Heae Surng Park; Hyun Yang Yeo; Hee Jin Chang; Kyung-Hee Kim; Ji Won Park; Byung Chang Kim; Ji Yeon Baek; Sun Young Kim; Dae Yong Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.